International
Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions. Optiscan Imaging (ASX: OIL) has begun Stage 2 of its first-in-human head and neck...
July 9, 2026 - Lumito AB (publ) ("Lumito" or the "Company") today announces that the Company has initiated a pilot project together with the Swedish biotech company Navinci Diagnostics AB (”Navinci”) to evaluate the possibilities of...
SAN JUAN, Puerto Rico--(BUSINESS WIRE)--CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first...
Tribun Health: A major new milestone in the digital transformation of pathology, benefiting laboratories, clinicians, and patients. Following FDA clearance in 2025, CaloPix's® IVDR certification confirms Tribun Health's ability to serve the...
Partnership grants Bioptimus access to unique European cohort of data Fédération Francophone de Cancérologie Digestive to share high quality clinical data of 3,000 GI cancer patients Significant progress in the STELA programme to...
Ibex Top experts Dr. Ruth March and Dr. Paolo Tarantino named as members, with additional appointments to follow TEL AVIV, Israel – May 5, 2026 – Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today...
